Xtrackers USD High Yield ... (HYLB)
35.42
0.10 (0.28%)
At close: Apr 15, 2025, 3:59 PM
35.44
0.03%
After-hours: Apr 15, 2025, 08:00 PM EDT
0.28% (1D)
Bid | 35.19 |
Market Cap | 3.91B |
AUM | 3.49B |
NAV | 35.88 |
EPS (ttm) | n/a |
PE Ratio (ttm) | n/a |
Shares Out | 111.03M |
Inception Date | Dec 13, 2016 |
Ask | 35.64 |
Volume | 1.46M |
Open | 35.41 |
Previous Close | 35.32 |
Day's Range | 35.37 - 35.49 |
52-Week Range | 34.40 - 36.94 |
Holdings | 1.11K |
Expense Ratio | 0.05% |
About HYLB
The fund will normally invest at least 80% of its net assets, plus the amount of any borrowings for investment purposes, in high yield corporate bonds. The index comprised of U.S. dollar-denominated high yield corporate bonds. It will concentrate its investments (i.e., hold 25% or more of its total assets) in a particular industry or group of industries to the extent that its underlying index is concentrated. The fund is non-diversified.
Asset Class Equity
Ticker Symbol HYLB
Inception Date Dec 13, 2016
Provider Xtrackers
Website Fund Home Page
Top 10 Holdings 5.75% of assets
Name | Symbol | Weight |
---|---|---|
Cash & Cash Equivale... | - | 2.28% |
Echostar Corp 10.75 ... | - | 0.56% |
Mozart Debt Merger S... | US293844001 | 0.41% |
Quikrete Holdings In... | - | 0.39% |
Picard Midco Inc 6.5... | 88632QAE3 | 0.39% |
Cloud Software Group... | US431429001 | 0.38% |
Dish Network Corp 11... | US393133001 | 0.37% |
Hub International Lt... | US446024001 | 0.33% |
Teva Pharmaceutical ... | 88167AAE1 | 0.32% |
Cco Holdings Llc 5.1... | 1248EPBT9 | 0.32% |
Dividends Dividend Yield 6.32%
Ex-Dividend | Amount | Payment Date |
---|---|---|
Apr 1, 2025 | $0.1820 | Apr 8, 2025 |
Mar 3, 2025 | $0.1759 | Mar 10, 2025 |
Feb 3, 2025 | $0.1972 | Feb 10, 2025 |
Dec 23, 2024 | $0.2191 | Dec 31, 2024 |
Dec 2, 2024 | $0.1888 | Dec 13, 2024 |

4 months ago · seekingalpha.com
The High-Yield Bond ETF HYLB Outshines Main Street Capital At 80% PremiumMAIN Street Capital's Q3 2024 results show a 10.8% gross assets yield and an 18.4% ROE, though the latter is debated due to variable gains. MAIN's future ROE may decline due to higher refinancing cost...